glp-1 medications side effects Adverse of class drugs. Gastrointestinal issues are GLP-1 Medications for Weight Loss:

However, up to 89% of participants taking efinopegdutide experienced gastrointestinal adverse events (mostly nausea, vomiting and diarrhoea) relative to 28% taking placebo and 60% taking liraglutide (86)

It is a product tradeoff

Although most attention has focused on diabetic retinopathy risks during rapid glycemic improvement, we must not overlook the potential for ischemic optic events

Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin

Bain, A

If youre ready to take control of your appetite and overall health, schedule a consultation with Dr